Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

20.51
+0.61003.07%
Volume:417.60K
Turnover:8.50M
Market Cap:1.78B
PE:-5.70
High:20.64
Open:19.97
Low:19.78
Close:19.90
52wk High:22.73
52wk Low:8.58
Shares:86.91M
Float Shares:72.72M
Volume Ratio:0.45
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6004
EPS(LYR):-3.7228
ROE:-129.32%
ROA:-39.24%
PB:15.44
PE(LYR):-5.51

Loading ...

Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2025

Major Issues Report

Form 8-K - Current report
Oct 24, 2025

Major Issues Report

Form 8-K - Current report
Sep 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2025

Major Issues Report

Form 8-K - Current report
Jul 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]